IHS Healthcare and Pharma Blog
Brazil
Trade envoy galvanises UK firms to invest in Brazilian healthcare
After a swift passage through the security check-point, that included an airport style search, I was officially inside the UK House of Commons on 25th January. Not only was this my first visit to the House of Commons, but also the first time a Brazilian Health and Life Sciences Seminar has taken place in the … Continue reading
A Latin Angle to Analysing Healthcare Systems
I wished I had practiced French beyond my school days was among my first thoughts when I attended the XXII congress of the Latin Association of Health Systems (ALASS) from 9 to 11 September in Lisbon, Portugal. A significant portion of the conference was dedicated to themed sessions, which had no simultaneous translation since the … Continue reading
Bye Bye CITEC, Hello CONITEC — Brazil’s New HTA Agency Aims for Stricter Reimbursement Requirements
Whilst conducting research on the Brazilian market for our latest multi-client study: The New REAlity of Relative Effectiveness — International Comparison of Evolving Requirements, I looked in detail at the major reform that has led to the newly formed HTA body, CONITEC. CONITEC stands for the National Commission for Incorporation of Technologies in the Unified … Continue reading
Drug Prices in Brazil, Russia and Turkey – A Comparison of Trends in Three Emerging Pharmaceutical Markets
In my work developing and analysing our database of global drug prices, I frequently come across interesting pricing trends – particularly in the current economic climate. Recently, I looked into drug prices and trends in three emerging countries: Brazil, Russia and Turkey. While pharmaceutical market values in developed countries are slowing down, an opposite trend … Continue reading
Subscribe with RSS
